Does insurance cover GLP-1 weight loss medications?

Which GLP-1 medications are approved for weight loss?

Not all commonly discussed GLP-1 medications have the same FDA-approved indications.

Wegovy

Wegovy (semaglutide) is FDA-approved, together with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in eligible adults with obesity or adults with overweight who have at least one weight-related comorbid condition.

Wegovy is available as a once-weekly injection and as an oral tablet, with different dosing instructions.

Zepbound

Zepbound (tirzepatide) is FDA-approved, together with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in eligible adults with obesity or adults with overweight who have at least one weight-related comorbid condition.

Zepbound is also FDA-approved to treat moderate to severe obstructive sleep apnea in adults with obesity, and is administered as a subcutaneous injection — the FDA label describes it only as "injection, for subcutaneous use," and no oral dosage form is listed.

Ozempic

Ozempic (semaglutide injection) is FDA-approved to improve blood sugar control in adults with type 2 diabetes, together with diet and exercise. Ozempic is not FDA-approved specifically for chronic weight management.

Mounjaro

Mounjaro (tirzepatide) is FDA-approved to improve blood sugar control in adults and certain pediatric patients with type 2 diabetes, together with diet and exercise. Chronic weight management is not an approved indication under the Mounjaro label.

Why does the FDA indication matter for insurance?

Insurance plans often build coverage criteria around a medication's FDA-approved indication, so a plan may treat the same medication differently depending on the condition for which it is prescribed. For example, coverage for Ozempic or Mounjaro for type 2 diabetes does not necessarily mean the plan will cover those medications when prescribed for weight loss.

What is a formulary?

A formulary is the list of prescription medications covered by an insurance or prescription drug plan. Your plan's formulary can tell you whether a GLP-1 is covered, which GLP-1 medications are covered, whether the medication has a preferred tier, whether prior authorization is required, whether you must try another medication first, and whether your plan excludes weight-loss medications entirely.

A medication appearing on a formulary does not necessarily mean that every patient will receive coverage — your plan may still require you to meet specific clinical criteria.

What is prior authorization for a GLP-1?

Prior authorization is a process in which an insurer reviews a requested prescription or treatment before deciding whether it meets the plan's coverage requirements. For GLP-1 medications, a plan may ask your clinician for your diagnosis, medical history, BMI or other eligibility information, previous treatments you have tried, relevant medical conditions, and why the requested medication is medically appropriate.

Many commercial insurance plans require prior authorization for brand-name GLP-1 medications. For plans and issuers subject to applicable federal rules, a pre-service prior authorization determination generally must be made within 15 calendar days, although different rules can apply in particular circumstances.

Prior authorization does not necessarily guarantee that your health plan will pay the final cost of the medication — your actual out-of-pocket cost can depend on your deductible, copay, coinsurance, pharmacy benefit, formulary tier, and other terms of your plan.

Insurance coverage by plan type

Commercial and employer insurance

Commercial and employer-sponsored insurance plans vary widely. Some plans cover anti-obesity medications, while others exclude them, and even when a plan covers a medication, prior authorization or other utilization-management requirements may apply.

For eligible patients with commercial insurance, Measured performs benefits checks to determine which medications may be covered under the patient's specific plan. Measured currently works with patients using commercial insurance plans including Aetna, Anthem, Blue Cross Blue Shield, Cigna, and UnitedHealthcare when coverage is available through the patient's benefits. Being insured by one of these companies does not guarantee coverage for a particular GLP-1 — your individual plan determines your benefits.

Medicare

Since the inception of the Medicare Part D program, CMS has interpreted the statutory exclusion of "agents when used for weight loss" to mean anti-obesity medications are coverable under Part D only when used for a medically accepted indication other than weight loss or weight management.

Medicare coverage rules have also changed in 2026 because of the Medicare GLP-1 Bridge, a CMS demonstration running from July 1, 2026 through December 31, 2027. Eligible Medicare Part D beneficiaries can access certain GLP-1 medications through the program for a $50 monthly copay, subject to the program's eligibility and prior-authorization requirements, operating outside the normal Medicare Part D benefit and payment flow. As of August 2026, CMS lists three products for the Medicare GLP-1 Bridge when used to reduce excess body weight and maintain weight reduction: Foundayo (tablet), Wegovy (injection or tablet), and Zepbound KwikPen. CMS specifies that only the KwikPen formulation of Zepbound is included; the single-dose vial and single-dose pen formulations are not.

The Medicare GLP-1 Bridge is not available to every Medicare beneficiary. Eligibility depends on the beneficiary's Medicare plan type, the reason for treatment, clinical criteria, and other program requirements. A beneficiary who has a GLP-1 indication already coverable under the regular Part D benefit may need to use the Part D plan's existing coverage or formulary-exception process rather than the Bridge — CMS identifies moderate to severe obstructive sleep apnea in adults with obesity, and reduction of cardiovascular risk in certain patients, as examples of uses coverable under Part D.

Medicaid and Marketplace insurance

Medicaid and Marketplace coverage varies by state and plan. There is no single national formulary that can tell you whether every Medicaid or Marketplace plan covers Wegovy, Zepbound, Ozempic, or Mounjaro — check your specific plan's formulary and coverage policy.

What if your insurance denies your GLP-1?

A denial does not necessarily mean you have no options. First, read the denial notice carefully. A notice of adverse benefit determination should explain the reason for the denial, identify the denial code and its meaning, describe the criteria or guidelines used, and explain what additional information may be needed. Those details can help you determine whether you are dealing with a plan exclusion, a formulary restriction, a medical-necessity judgment, a prior-authorization problem, missing documentation, or another coverage requirement.

Can you appeal a GLP-1 denial?

In many cases, yes. For health plans subject to applicable federal internal and external review requirements, an enrollee generally has 180 days after receiving a denial notice to request an internal appeal, which generally must be completed within 30 days for a pre-service request.

If the denial remains after internal review, you may have the right to request an external review. A standard external review generally must be decided no later than 45 days after the request is received; expedited external reviews generally must be decided within 72 hours or less, depending on medical urgency. Your denial notice should explain your specific appeal rights and deadlines.

External review is generally free: there is no charge when the HHS-administered Federal External Review Process applies, and the plan or issuer pays the independent review organization. Only states that expressly allowed a filing fee as of November 18, 2015 may still charge one, capped at $25 per external review. As of July 1, 2026, that process is temporarily unavailable for certain enrollees in Alabama, Florida, Georgia, Texas, Wisconsin, and U.S. territories other than Puerto Rico — insurance companies in all states must still offer an external review process that meets federal consumer protection standards, so if this applies to you, follow the instructions in your plan's notice regarding where to request external review.

What if the GLP-1 isn't on my formulary?

If a prescribed medication is not normally covered, you may be able to request a formulary exception through your insurance plan. Your clinician generally needs to explain why the requested medication is medically appropriate for your condition. Your plan's exception process and requirements should be listed in your coverage documents or denial notice.

How much do GLP-1 medications cost without insurance?

If your insurance does not cover your medication, your alternatives may include manufacturer programs, cash-pay programs, or other options. The amount you actually pay can vary significantly.

Example prices as of August 2026; prices can change and may have eligibility, dosage, or program requirements. Do not use a manufacturer's list price as an estimate of what you personally will pay — insured patients may pay substantially less depending on their benefits.

As of August 2026, the Wegovy list price is $1,349.02 per package before rebates or discounts, and most insured patients pay less. Mounjaro's wholesale acquisition cost is $1,079.77 per carton of four single-dose pens, based on the January 2025 price referenced by Measured — a manufacturer price, not necessarily what a patient pays at the pharmacy.

How Measured helps with insurance coverage

For eligible patients with commercial insurance, Measured can help with the insurance process:

1. Benefits check — Measured checks your insurance benefits to determine which medications may be covered under your plan.
2. Prior authorization support — If prior authorization is required, Measured's insurance concierge team can submit it on your behalf and keep you updated on the plan's determination.
3. Pharmacy fulfillment — When a GLP-1 is covered by insurance, Measured sends the prescription to the patient's pharmacy of choice.
4. Cash-pay options — When insurance coverage is not available, Measured offers cash-pay options for eligible patients.

Measured membership fees are paid separately and are not covered by insurance. No insurance approval, medication coverage, or treatment outcome is guaranteed. As of August 2026, Measured is available in 26 states and says its service area represents roughly 80% of the U.S. population.

What if my insurance doesn't cover a GLP-1?

You may still have options, depending on your circumstances: a different medication covered by your plan, a formulary exception, an insurance appeal, a manufacturer savings or patient-assistance program when eligible, a cash-pay medication, or another medically appropriate treatment discussed with your clinician.

As of August 2026, Measured lists Wegovy and Zepbound as available with and without insurance, while Ozempic and Mounjaro are listed as requiring insurance. Medication and membership pricing vary by product and program.

Is compounded semaglutide covered by insurance?

Coverage varies, but compounded medications are generally handled differently from FDA-approved branded medications. Measured lists compounded semaglutide as a cash-pay option with medication included in membership pricing, starting at $119/month as of August 2026.

Compounded drugs are not FDA-approved, meaning the FDA does not review them before marketing to evaluate their safety, effectiveness, or quality the way it reviews FDA-approved drugs. Whether a compounded medication is appropriate for you should be discussed with a qualified clinician.

The bottom line

Insurance can cover GLP-1 medications for weight loss, but coverage is determined by your specific plan — not simply by the name of your insurer.

Before paying cash for a GLP-1, check whether the medication is on your formulary, whether your plan covers weight-management medications, whether prior authorization is required, what clinical criteria you must meet, and what your expected out-of-pocket cost will be.

Insurance coverage, medication availability, eligibility requirements, and pricing can change. This article is for informational purposes and does not guarantee insurance coverage, approval, or treatment outcomes.